Platelet density in essential thrombocythemia and polycythemia vera

被引:8
|
作者
Järemo, P [1 ]
机构
[1] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA
关键词
D O I
10.1080/09537109976365
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study aims to compare platelet density in myeloproliferative disorders (essential thrombocythemia (ET) and polycythemia vera (PV)) with platelet density of healthy subjects. Platelet density peaks mere determined using a specially designed apparatus for scanning light transmission variations along test tubes containing density-separated platelets. Eighteen patients with myeloproliferative disorders (nine ET and nine PV) were compared with a control group consisting of 12 healthy volunteers. Compared with healthy volunteers, patients with myeloproliferative disorders had significantly lower platelet peak density (P < 0.001). It is concluded that determination of peak platelet density may be a useful tool for excluding ET and PV. A high platelet density peak makes a clonal disorder less likely and a low density peak would confirm the suspicion.
引用
收藏
页码:61 / 63
页数:3
相关论文
共 50 条
  • [41] Part 2: Essential thrombocythemia and polycythemia vera - Preface
    Mammen, EF
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (04): : 305 - 306
  • [42] Management of symptoms in polycythemia vera and essential thrombocythemia patients
    Radia, Deepti
    Geyer, Holly L.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 340 - 348
  • [43] Evidence and expertise in the management of polycythemia vera and essential thrombocythemia
    Finazzi, G.
    Barbui, T.
    [J]. LEUKEMIA, 2008, 22 (08) : 1494 - 1502
  • [44] Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
    Silver, Richard T.
    Kiladjian, Jean-Jacques
    Hasselbalch, Hans Carl
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 49 - 58
  • [45] Is myocardial infarction as frequent in essential thrombocythemia as in polycythemia vera?
    Randi, ML
    Rossi, C
    Zerbinati, P
    Girolami, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : PS182 - PS182
  • [46] Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
    H Reikvam
    R V Tiu
    [J]. Leukemia, 2012, 26 : 563 - 571
  • [47] MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients
    Zhan, Huichun
    Cardozo, Christopher
    Yu, Wayne
    Wang, Antai
    Moliterno, Alison R.
    Dang, Chi V.
    Spivak, Jerry L.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2013, 50 (03) : 190 - 195
  • [48] Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia
    Murphy, S
    [J]. SEMINARS IN HEMATOLOGY, 1999, 36 (01) : 9 - 13
  • [49] Essential thrombocythemia following polycythemia vera: An unusual sequence
    Randi, ML
    Barbone, E
    Zerbinati, P
    Soini, B
    Rossi, C
    Girolami, A
    [J]. JOURNAL OF MEDICINE, 1996, 27 (5-6) : 363 - 368
  • [50] Current management strategies for polycythemia vera and essential thrombocythemia
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    [J]. BLOOD REVIEWS, 2020, 42